Format

Send to

Choose Destination
Nat Biotechnol. 2013 Oct;31(10):880-2. doi: 10.1038/nbt.2708.

The regulatory landscape for actively personalized cancer immunotherapies.

Author information

1
1] TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH, Mainz, Germany. [2] Ribological GmbH, Mainz, Germany. [3].
PMID:
24104749
DOI:
10.1038/nbt.2708
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center